Dachaigh › Neuroblastoma › Michigan
Sgrùdaidhean clionaigeach Neuroblastoma ann an Michigan
Tha 8 sgrùdaidhean airson Neuroblastoma a’ lorg phàirtichean aig làraichean ann an Michigan.
Bailtean ann an Michigan
Teacsa sgrùdaidh oifigeil (Beurla)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- C S Mott Children's Hospital, Ann Arbor
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Bronson Methodist Hospital, Kalamazoo
- agus 1 a bharrachd
A’ fastadhÌre 3
Suas gu aois 30 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Corewell Health ( Site 1001), Grand Rapids
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06395103Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Helen DeVos Children's Hospital, Grand Rapids
A’ fastadhÌre 2
Suas gu aois 22 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT02559778Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Hospital of Michigan/Wayne State University, Detroit
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- C S Mott Children's Hospital, Ann Arbor
- Children's Hospital of Michigan, Detroit
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- agus 2 a bharrachd
A’ fastadhÌre 3
365 Days – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- C.S Mott Children's Hospital, Ann Arbor
A’ fastadhÌre 2
Aoisean 1 gu 31 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT06450041Neuroblastoma Biology Study
- C.S Mott Children's Hospital, Ann Arbor
A’ fastadhSgrùdadh amharc
31 Days – 99 Years · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT01587300Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.